May 22, 2017 12:35 pm UTC| Business
NEW YORK, May 22, 2017 -- Tyme Technologies, Inc. (OTCQB:TYMI), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced that it will present data from its...
May 22, 2017 12:35 pm UTC| Business
NEW YORK, May 22, 2017 -- Tyme Technologies, Inc. (OTCQB:TYMI), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced that it will present data from its...
May 22, 2017 12:35 pm UTC| Business
NEW YORK, May 22, 2017 -- Tyme Technologies, Inc. (OTCQB:TYMI), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced that it will present data from its...
May 22, 2017 12:35 pm UTC| Business
NEW YORK, May 22, 2017 -- Tyme Technologies, Inc. (OTCQB:TYMI), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced that it will present data from its...
Adverum Biotechnologies to Present at the Jefferies Global Healthcare Conference
May 22, 2017 12:34 pm UTC| Business
MENLO PARK, Calif., May 22, 2017 -- Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a leading gene therapy company advancing novel medicines to address unmet needs in serious rare and ocular diseases, announced today that...
Adverum Biotechnologies to Present at the Jefferies Global Healthcare Conference
May 22, 2017 12:34 pm UTC| Business
MENLO PARK, Calif., May 22, 2017 -- Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a leading gene therapy company advancing novel medicines to address unmet needs in serious rare and ocular diseases, announced today that...
Adverum Biotechnologies to Present at the Jefferies Global Healthcare Conference
May 22, 2017 12:34 pm UTC| Business
MENLO PARK, Calif., May 22, 2017 -- Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a leading gene therapy company advancing novel medicines to address unmet needs in serious rare and ocular diseases, announced today that...